Received Feb 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 3 | — | — |
Sjogrens disease; autoimmune response; This is a spontaneous report received from a Consumer or other non HCP. A 28-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: BNT162b2 (Dose 1, single, lot number: 1894792, Facility type vaccine: Hospital), administration date: 17Dec2020, when the patient was 27-year-old, for Covid-19 immunisation; Bnt162b2 (Dose 2, single), for Covid-19 immunisation. The patient had no known allergy. The patient did not had other vaccine same date. No other vaccine in four weeks; No other medications in two weeks. The following information was reported: SJOGREN'S SYNDROME (medically significant) with onset 10Oct2022, outcome "not recovered", described as "Sjogrens disease"; AUTOIMMUNE DISORDER (medically significant) with onset 10Oct2022, outcome "not recovered", described as "autoimmune response". Clinical course: Developed Sjogrens disease after getting two doses of Covid shot and booster. No family history of autoimmune disease and no symptoms prior to Covid shot. The patient was wondering with new info that Covid vaccine can cause autoimmune response if she developed Sjogrens due to Covid vaccine. The patient was on chronic medications for autoimmune disease. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.
Medical History/Concurrent Conditions: Anxiety